Back to Search
Start Over
Serum PD-1 levels measured by ELISA using Nivolumab increased in advanced RCC patients: novel approach to develop companion diagnostics for antibody therapy
- Source :
- Journal of Cancer Research and Clinical Oncology
- Publication Year :
- 2018
- Publisher :
- Springer Berlin Heidelberg, 2018.
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
Companion diagnostics
Programmed Cell Death 1 Receptor
Enzyme-Linked Immunosorbent Assay
Letter to the Editors
Programmed cell death ligand 1
Antineoplastic Agents, Immunological
Renal cell carcinoma
Programmed cell death 1
Internal medicine
Programmed cell death ligand-1
Medicine
Humans
Carcinoma, Renal Cell
Hematology
biology
business.industry
Programmed cell death-1
Reproducibility of Results
General Medicine
medicine.disease
Kidney Neoplasms
Nivolumab
biology.protein
Immunotherapy
business
Antibody therapy
Subjects
Details
- Language :
- English
- ISSN :
- 14321335 and 01715216
- Volume :
- 145
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- Journal of Cancer Research and Clinical Oncology
- Accession number :
- edsair.doi.dedup.....094e79705cd8346a167e84c675725b0d